CA
Corriente Advisors Portfolio holdings
AUM
$3.45M
This Quarter Return
+1.96%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(-32%)
Cap. Flow
-$85M
Cap. Flow
% of AUM
-45.82%
Top 10 Holdings %
Top 10 Hldgs %
92.79%
Holding
19
New
9
Increased
–
Reduced
6
Closed
4
Top Buys
| 1 |
Coinbase
COIN
|
$10.1M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$10.1M |
| 3 |
QuantumScape
QS
|
$9.87M |
| 4 |
Kratos Defense & Security Solutions
KTOS
|
$7.86M |
| 5 |
MP Materials
MP
|
$4.06M |
Top Sells
| 1 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
$29.1M |
| 2 |
Replimune Group
REPL
|
$24M |
| 3 |
Teledyne Technologies
TDY
|
$22.8M |
| 4 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
$21.2M |
| 5 |
Meta Platforms (Facebook)
META
|
$14.7M |
Sector Composition
| 1 | Technology | 43.15% |
| 2 | Healthcare | 36.46% |
| 3 | Financials | 5.46% |
| 4 | Consumer Discretionary | 5.32% |
| 5 | Industrials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
1
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $76.7M | 41.35% | 1,920,333 -729,667 | -28% | -$29.1M |
|
2
Cue Biopharma
CUE
$60M
| $17.3M | 9.34% | 1,486,986 -1,062,045 | -42% | -$12.4M |
|
|
3
Replimune Group
REPL
$422M
| $17.3M | 9.32% | 449,879 -625,121 | -58% | -$24M |
|
|
4
Coinbase
COIN
$78.2B
| $10.1M | 5.46% | +40,000 | New | +$10.1M |
|
|
RETA
5
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $10.1M | 5.43% | +71,115 | New | +$10.1M |
|
|
6
QuantumScape
QS
$4.49B
| $9.87M | 5.32% | +337,316 | New | +$9.87M |
|
7
Lantern Pharma
LTRN
$44.1M
| $9.58M | 5.17% | 656,364 -57,442 | -8% | -$839K |
|
8
Cardiff Oncology
CRDF
$140M
| $9.2M | 4.96% | 1,383,500 -1,401,910 | -50% | -$9.32M |
|
|
9
Kratos Defense & Security Solutions
KTOS
$11.1B
| $7.86M | 4.24% | +275,738 | New | +$7.86M |
|
|
10
MP Materials
MP
$12.6B
| $4.06M | 2.19% | +110,000 | New | +$4.06M |
|
|
HIMX
11
Himax Technologies
HIMX
$1.42B
| $3.33M | 1.8% | +200,000 | New | +$3.33M |
|
12
CRISPR Therapeutics
CRSP
$4.71B
| $3.24M | 1.75% | +20,000 | New | +$3.24M |
|
13
Iridium Communications
IRDM
$2.64B
| $3.2M | 1.73% | +80,000 | New | +$3.2M |
|
14
Roblox
RBLX
$86.4B
| $2.7M | 1.46% | +30,000 | New | +$2.7M |
|
15
DiaMedica Therapeutics
DMAC
$295M
| $906K | 0.49% | 203,641 -666,587 | -77% | -$2.97M |
|
16
EyePoint Pharmaceuticals
EYPT
$797M
| – | – | -200,000 | Closed | -$2.03M |
|
|
17
Meta Platforms (Facebook)
META
$1.86T
| – | – | -50,000 | Closed | -$14.7M |
|
|
TFFP
18
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| – | – | -1,565,682 | Closed | -$21.2M |
|
|
19
Teledyne Technologies
TDY
$25.2B
| – | – | -55,000 | Closed | -$22.8M |
|